🚀 VC round data is live in beta, check it out!
ABVC BioPharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for ABVC BioPharma and similar public comparables like Above Food, Local Bounti, Steakholder Foods, Moolec Science and more.
ABVC BioPharma Overview
About ABVC BioPharma
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Founded
2015
HQ
Employees
19
Website
Sectors
Financials (FY)
EV
$39M
ABVC BioPharma Financials
ABVC BioPharma reported last fiscal year revenue of — and negative EBITDA of ($7M).
In the same fiscal year, ABVC BioPharma generated — in gross profit, ($7M) in EBITDA losses, and had net loss of ($8M).
Revenue (LTM)
ABVC BioPharma P&L
In the most recent fiscal year, ABVC BioPharma reported revenue of — and EBITDA of ($7M).
ABVC BioPharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($7M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($8M) | XXX | XXX | XXX |
| Net Debt | — | — | $873K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
ABVC BioPharma Stock Performance
ABVC BioPharma has current market cap of $37M, and enterprise value of $39M.
Market Cap Evolution
ABVC BioPharma's stock price is $1.43.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $39M | $37M | 1.4% | XXX | XXX | XXX | $-0.31 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialABVC BioPharma Valuation Multiples
ABVC BioPharma trades at (5.3x) EV/EBITDA.
EV / Revenue (LTM)
ABVC BioPharma Financial Valuation Multiples
As of April 11, 2026, ABVC BioPharma has market cap of $37M and EV of $39M.
Equity research analysts estimate ABVC BioPharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
ABVC BioPharma has a P/E ratio of (4.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $37M | XXX | $37M | XXX | XXX | XXX |
| EV (current) | $39M | XXX | $39M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (5.3x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (5.5x) | XXX | XXX | XXX |
| P/E | — | XXX | (4.6x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (13.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified ABVC BioPharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
ABVC BioPharma Margins & Growth Rates
ABVC BioPharma's revenue in the last fiscal year declined by (100%).
ABVC BioPharma's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.
ABVC BioPharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 71% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
ABVC BioPharma Public Comps
See public comps and valuation multiples for other Plant-Based Food comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Above Food | XXX | XXX | XXX | XXX | XXX | XXX |
| Local Bounti | XXX | XXX | XXX | XXX | XXX | XXX |
| Steakholder Foods | XXX | XXX | XXX | XXX | XXX | XXX |
| Moolec Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Jyong Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ABVC BioPharma M&A Activity
ABVC BioPharma acquired XXX companies to date.
Last acquisition by ABVC BioPharma was on XXXXXXXX, XXXXX. ABVC BioPharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by ABVC BioPharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialABVC BioPharma Investment Activity
ABVC BioPharma invested in XXX companies to date.
ABVC BioPharma made its latest investment on XXXXXXXX, XXXXX. ABVC BioPharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by ABVC BioPharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout ABVC BioPharma
| When was ABVC BioPharma founded? | ABVC BioPharma was founded in 2015. |
| Where is ABVC BioPharma headquartered? | ABVC BioPharma is headquartered in United States. |
| How many employees does ABVC BioPharma have? | As of today, ABVC BioPharma has over 19 employees. |
| Who is the CEO of ABVC BioPharma? | ABVC BioPharma's CEO is Uttam Yashwant Patil. |
| Is ABVC BioPharma publicly listed? | Yes, ABVC BioPharma is a public company listed on Nasdaq. |
| What is the stock symbol of ABVC BioPharma? | ABVC BioPharma trades under ABVC ticker. |
| When did ABVC BioPharma go public? | ABVC BioPharma went public in 2004. |
| Who are competitors of ABVC BioPharma? | ABVC BioPharma main competitors are Above Food, Local Bounti, Steakholder Foods, Moolec Science. |
| What is the current market cap of ABVC BioPharma? | ABVC BioPharma's current market cap is $37M. |
| Is ABVC BioPharma profitable? | No, ABVC BioPharma is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.